Navigation Links
Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
Date:11/28/2007

ST. LOUIS, Nov. 29 /PRNewswire-FirstCall/ -- Sigma-Aldrich(TM) (Nasdaq: SIAL) announced that its laboratory for the production of Certified Reference Materials (CRM) in Buchs, Switzerland, received double accreditation following ISO/IEC 17025 "General requirements for the competence of testing and calibration laboratories" and ISO Guide 34 "General requirements for the competence of reference material producers."

For Reference Materials producers, this combination of accreditations is the highest achievable level of quality assurance. CRM, which are produced under these guidelines, are characterized by highest accuracy and comprehensive documentation. The certificates contain all information about purity, traceability, uncertainty and expiration dates, as well as handling and storing instructions. With the recently introduced TraceCERT(R) product line (http://www.sigma-aldrich.com/tracecert), Sigma-Aldrich has launched its first CRM series produced under this double accreditation.

"In analytical chemistry, the reliability of products is of crucial importance, because it directly impacts our customers' results. This double accreditation confirms our outstanding expertise as a producer of analytical standards. It recognizes our efforts in R&D, Quality Control and production and brings us into a leading position. We are very proud to join a select group of institutes and companies worldwide working at this level of certified quality," said Dave Julien, President of the Research Specialties business unit at Sigma-Aldrich.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has custom
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...STON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd.,...8pandemicthroughtheprediction,outbreak,andprogress...emicalanalysisofthevirus.Thenewdatashowsthatthelet...eakof3.7(s.d.4.5)duringthevirus,scurrentoutbreakin...of2.0(s.d.0.1).TheH1N1virus,infectivitycount,howev...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, BrazilBioethanolMarketAnalysisandFore...165503/Brazil-Bioethanol-Market-Analysis-and-Forec...lysisandForecaststo2013 ,, Summary ,, Ther...albioethanolmarketandtheBrazilbioethanolmarketinpa...
(Date:11/24/2009)... The New York investment bank KTA C...U) has agreed an AU$6.7 mil convertible note priva...he private placement was arranged by KTA Capital a... , New York (PRWEB) Novemb... bank KTA Capital, LLC ("KTA Capital") h...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...edical Systems, Growing Network of Medical Technol...Year of Profitability in 2007., PLEASANTON, Calif...an office in Russia to open a distribution network...lted in the registration of DMS,s,InNovaSound USB ... medical,providers in Russia., (Logo: http://www...
..., Calif., May 16 Immunosyn,Corporation (OTC Bulle...tained exclusive worldwide marketing, sales and di... from its affiliate Argyll Biotechnologies,LLC, ha...ch 31, 2008., For the quarter ended March 31, 200... administrative expenses and $13,393.00 in interes...
..., Calif., May 16 InterMune, Inc.,(Nasdaq: ITMN )...esident and,Chief Financial Officer of InterMune, ...re Conference in New York on May 22, 2008 at 1:30 ...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Other Biology Technology:Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3
(Date:11/24/2009)...held secrets of the earth,s history locked in its ...y little information on the environments that have...years. Now, a team of researchers from nine instit...e of $10 million dollars by the National Science F... literally. These scientists will drill through th...
(Date:11/23/2009)...ociated strain of the deadly superbug MRSAan infec...ibioticsposes a far greater health threat than pre..., according to a study in the December issue of E...is easily picked up in fitness centers, schools, a...ll burden of MRSA within hospitals, the report fou...
(Date:11/23/2009)...ggests that a common oral bacterium may exacerbate...s et al, "Unique Lipids from a Common Human Bacter...of Enhancing Autoimmunity," appears in the Decembe... . , Multiple sclerosis (MS), a disease where th... affects nearly 1 in 700 people in the United Stat...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...more than half of children with sore throat, excee...used nonrecommended antibiotics for 27 percent of ...according to a study in the November 9 issue of JA...ounts for 6 percent of visits by children to famil... to background information in the article. The mos...
...e have demonstrated that Langerhans cells in the s...stem to pathogens, instead dampen the skin,s react...potential to significantly alter understanding of ... as psoriasis, lupus and skin cancer. , Dendriti...emely efficient at alerting the immune system to t...
...iated with an increased risk of hypertension in wo...nsumption of sugared or diet colas, according to a...ately 50 million people in the United States have ...cording to background information in the article. ...eart disease, stroke, and congestive heart failure...
Other Biology News:Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Hae III (High Concentration) from Takara Mirus Bio
Sma I (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Mouse Anti-beta-III-Tubulin Monoclonal Antibody, Unconjugated, Clone TU-20 from BioVendor Laboratory Medicine, Inc.
Biology Products: